Antiparasitic Drugs Market

Antiparasitic Drugs Market, By Product Type (Anthelmintics (Anticestodal Drugs, Antitrematodal Drugs, and Antinematodal Drugs) Antiprotozoal Agents (Antimalarials Agents Antibabesial Agents, Antiamoebic Agents, and Others (Trypanocidal Agents, Antileishmanial Agents, etc.)), Ectoparasiticide (Antiscabietic Agents and Pediculicides)), By Route Of Administration (Oral, Injectable, and Topical), By Application (Human Health, Animal Health, Crop Health) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Antiparasitic drugs are utilized to address various types of infections caused by a wide array of parasites. Parasites are small organisms that reside on or inside humans and animals. There are numerous antiparasitic drugs available, each designed to target a specific parasite. Parasitic infections can arise from a multitude of parasites, with the three main types being ectoparasites, helminthes, and protozoa. Antiparasitic drugs play a crucial role in treating these infections. For example, anticestodal drugs are effective against tapeworms, antitrematodal drugs target flukes, antinematodal drugs are designed to combat roundworms, and antimalarial agents are employed in the treatment of malaria. Additionally, there are specific antiparasitic drugs such as antibabesial agents for Babesiosis, antiamoebic agents for amoebic infections, trypanocidal agents for trypanosomiasis, antileishmanial agents for leishmaniasis, antiscabietic agents for scabies, and pediculicides for lice infestations. These different classes of antiparasitic drugs help address the varied range of parasitic infections and play a vital role in the overall management and treatment of these conditions.

Market Dynamics

Initiatives and campaigns by governments, non-profit organizations, and market players like Novartis are underway to promote the widespread use of antiparasitic drugs and enhance the treatment of tropical diseases, including parasitic illnesses such as malaria, leishmaniasis, and Chagas disease. These efforts aim to increase the demand for antiparasitic drugs and consequently drive the growth of the global antiparasitic drugs market in the foreseeable future. For instance, in October 2021, the U.S. President's Malaria Initiative (PMI) introduced a new five-year strategy called 'End Malaria Faster'. The primary objective of this strategy is to eliminate malaria within a generation, aligning with global targets of saving over 4 million lives and preventing 1 billion cases by 2025. The five-year PMI strategy focuses on reducing health disparities, enhancing disease surveillance, and continuing to save lives. These proactive measures by various stakeholders, such as governments and organizations like Novartis, in combating parasitic diseases and promoting the use of antiparasitic drugs demonstrate a concerted effort to address the burden of these conditions and improve public health outcomes.

Key features of the study:
  • This report provides in-depth analysis of the global antiparasitic drugs market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global antiparasitic drugs market based on the following parameters– company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Merck KGaA, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd, Cipla Limited, Cadila Pharmaceuticals, Watson International Limited, Vivaldis, Glenmark Pharmaceuticals Limited, Viatris Inc., Novartis AG, AdvaCare Pharma, Lupin, Sun Pharmaceutical Industries Ltd., and Aurobindo Pharma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global antiparasitic drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antiparasitic drugs market
Detailed Segmentation:
  • Global Antiparasitic Drugs Market, By Product Type:
  • Anthelmintics
  • Anticestodal Drugs
  • Antitrematodal Drugs
  • Antinematodal Drugs
  • Antiprotozoal Agents
  • Antimalarials Agents
  • Antibabesial Agents
  • Antiamoebic Agents
  • Others (Trypanocidal Agents, Antileishmanial Agents, etc.)
  • Ectoparasiticide
  • Antiscabietic Agents
  • Pediculicides
  • Global Antiparasitic Drugs Market, By Route of Administration:
  • Oral
  • Injectable
  • Topical
  • Global Antiparasitic Drugs Market, By Application:
  • Human Health
  • Animal Health
  • Crop Health
  • Global Antiparasitic Drugs Market, By Region:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Merck KGaA.
  • GlaxoSmithKline plc.
  • Reddy’s Laboratories Ltd
  • Cipla Limited
  • Cadila Pharmaceuticals
  • Watson International Limited
  • Vivaldis
  • Viatris Inc.
  • Novartis AG
  • AdvaCare Pharma
  • Lupin
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Glenmark Pharmaceuticals Limited


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Route Of Administration
Market Snapshot, By Application
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Attractiveness Analysis
Market Opportunities
Merger, Acquisition, Collaborations
Funding and Investment
Future Prospective of Antiparasitic Drugs
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
PORTER’s Analysis
4. Global Antiparasitic Drugs Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Antiparasitic Drugs Market, By Product Type, 2018–2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Anthelmintics
Anticestodal Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Antitrematodal Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Antinematodal Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Antiprotozoal Agents
Antimalarials Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Antibabesial Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Antiamoebic Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Others (Trypanocidal Agents, Antileishmanial Agents, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Ectoparasiticide
Antiscabietic Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Pediculicides
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
6. Global Antiparasitic Drugs Market, By Route of Administration, 2018 -2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segments Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
7. Global Antiparasitic Drugs Market, By Application, 2018 – 2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segments Trends
Human Health
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Animal Health
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
Crop Health
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
8. Global Antiparasitic Drugs Market, By Region, 2018 – 2030, (US$ Billion)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region, 2018–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 – 2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 – 2030, (US$ Billion)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Merck KGaA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
GlaxoSmithKline plc
Cipla Limited
Cadila Pharmaceuticals
Watson International Limited
Vivaldis
Glenmark Pharmaceuticals Limited
Advanced Bioscience Laboratories, Inc.
Viatris Inc.
Novartis AG
AdvaCare Pharma
Lupin
Catalent, Inc
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
10. Section
Research Methodology
About Us
*Browse 32 market data tables and 36 figures on “Global Antiparasitic Drugs Market”- Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings